Sanara MedTech Inc. (SMTI) filer’s amended 13G shows exit from share ownership

Rhea-AI Filing Summary

Sanara MedTech Inc. received an amended Schedule 13G from investment advisor Christopher M. Plahm, relating to its common stock. The amendment reports that Plahm, Tall Pines Capital, LLC, and Stonebridge Wealth Management, LLC now beneficially own 0 shares of Sanara MedTech common stock, representing 0.0% of the class, with no sole or shared voting or dispositive power. The filing characterizes this as ownership of 5 percent or less of the class as of July 30, 2026.

Key Figures

Beneficially owned shares: 0 Percent of class owned: 0.0 % Sole voting power (shares): 0 +2 more

5 metrics

Beneficially owned shares 0 Amount beneficially owned in Sanara MedTech common stock reported in Item 4(a)

Percent of class owned 0.0 % Percent of Sanara MedTech common stock class reported in Item 4(b)

Sole voting power (shares) 0 Sole power to vote or direct the vote over Sanara MedTech shares

Shared voting power (shares) 0.00 Shared power to vote or direct the vote for Tall Pines and Stonebridge

Filing date 07/30/2026 Date the amended Schedule 13G was signed by the investment advisor

Key Terms

Schedule 13G/A, beneficially owned, Sole Voting Power, Dispositive Power, +1 more

5 terms

Schedule 13G/A regulatory

"Sanara MedTech Inc. received an amended Schedule 13G"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 0"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Dispositive Power financial

"Sole Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class financial

"Percent of class: 0.0 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/31/2026 - 06:07 AM Accepted by SEC EDGAR 07/31/2026 - 06:02 AM Learn about SEC filing dates

FAQ

What does Sanara MedTech Inc. (SMTI) report in this Schedule 13G/A amendment?

The amendment shows Christopher M. Plahm and related entities now report 0 shares of Sanara MedTech common stock, equal to 0.0% of the class, with no voting or dispositive power remaining.

Who is the reporting person in the Sanara MedTech (SMTI) Schedule 13G/A?

The reporting person is Christopher M. Plahm, an investment advisor based at 1010 Jorie Blvd, Suite 144, Oak Brook, IL 60523, who filed the amended Schedule 13G regarding Sanara MedTech common stock.

What ownership percentage of Sanara MedTech (SMTI) does the filer report?

The filer reports beneficial ownership of 0.0% of Sanara MedTech’s common stock, with 0 shares beneficially owned and no sole or shared voting or dispositive power over any shares.

Which entities associated with the filer are mentioned in the Sanara MedTech (SMTI) 13G/A?

The amendment references Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC, each shown with 0.00 sole and shared voting power and 0.00 dispositive power, indicating no reportable beneficial ownership.

When was the amended Schedule 13G for Sanara MedTech (SMTI) signed?

The amended Schedule 13G was signed on 07/30/2026 by Christopher M. Plahm in his capacity as Investment Advisor, documenting the updated beneficial ownership status in Sanara MedTech common stock.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Sanara MedTech Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

79957L100

(CUSIP Number)

07/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 79957L100

1

Names of Reporting Persons

Tall Pines Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 79957L100

1

Names of Reporting Persons

Stonebridge Wealth Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Sanara MedTech Inc.
(b)	Address of issuer's principal executive offices: 1200 Summit Ave, Suite 414, Fort Worth, TX, 76102
Item 2.
(a)	Name of person filing: Christopher M. Plahm
(b)	Address or principal business office or, if none, residence: 1010 Jorie Blvd, Suite 144 Oak Brook, IL 60523
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 79957L100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Tall Pines Capital, LLC

Signature:	Christopher M. Plahm
Name/Title:	Investment Advisor
Date:	07/30/2026

Stonebridge Wealth Management, LLC

Signature:	Christopher M. Plahm
Name/Title:	Investment Advisor
Date:	07/30/2026